Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.3.44 (
P-glycoprotein
)
13,344
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
LRP130
is a ubiquitous protein involved in cellular homeostasis, microtubule alteration, and transactivation of a few multidrug resistance genes. Its role in resistance to apoptosis in HepG2 and HUH7 hepatocarcinoma cells was investigated. Using shRNA-producing lentiviruses to down-regulate the
LRP130
gene, we showed that i)
LRP130
did not affect the capacity of hepatocarcinoma cells to extrude drugs since
LRP130
down-regulation was insufficient to significantly reduce
P-glycoprotein
production in these cells, and ii) the expression of 11 apoptosis-related genes measured by PCR-array was significantly reduced. Interestingly, six of these genes encode extrinsic pathway proapoptotic proteins whose expression was higher in
LRP130
-non producing than in
LRP130
-producing HepG2 cells. Fluorescence microscopy confirmed this new anti-apoptotic role of
LRP130
, which is strengthened by a significantly reduced cytochrome c oxidase activity in
LRP130
-down-regulated hepatocarcinoma cells.
...
PMID:Leucine-rich protein 130 contributes to apoptosis resistance of human hepatocarcinoma cells. 2110 38